Is it safe to prescribe linagliptin 5 mg once daily at night for an elderly patient with type 2 diabetes, considering renal function and hypoglycemia risk?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the recommended dosage of linagliptina (diabetes medication) for a patient with type 2 diabetes?

What are the key characteristics of Tradjenta (linagliptin), including brand and generic name, dosage forms, pharmacologic category, FDA-approved indications, dosage and frequency, mechanism of action, contraindications, adverse effects, drug interactions, and patient counseling points?

Can linagliptin be administered at night?

Can linagliptin (Trajenta) be used together with oral semaglutide (Rybelsus) in a patient with type 2 diabetes?

How do I titrate Tradjenta (linagliptin)?

Can dapagliflozin be used in an elderly patient with type 2 diabetes, chronic kidney disease (CKD) with eGFR ≥ 30 mL/min/1.73 m², and established coronary artery disease (CAD)?

What is the appropriate low‑molecular‑weight heparin dosing for a pregnant woman with antiphospholipid syndrome, with or without prior thrombosis?

In a hemodynamically stable patient with diverticulosis presenting with severe left iliac fossa pain, constipation, localized tenderness, and CT showing a large intra‑abdominal collection without free intraperitoneal air, what is the most appropriate next management: colonoscopy, exploratory laparotomy, or percutaneous drainage?

What is the normal random blood‑sugar (RBS) range for a healthy 2‑year‑old child?

How should I manage a patient with secondary polycythemia who has a hemoglobin of 19.3 g/dL and a hematocrit of 61%?

What is the appropriate dosing, contraindications, monitoring, and precautions for mirabegron in adults with overactive bladder, including elderly patients or those with moderate renal or hepatic impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.